Last: | $34.39 |
---|---|
Change Percent: | 0.0% |
Open: | $34 |
Close: | $34.39 |
High: | $34.93 |
Low: | $34 |
Volume: | 258,673 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$34.39 | $34 | $34.39 | $34.93 | $34 | 258,673 | 05-01-2024 |
$34 | $33.7 | $34 | $34.18 | $33.65 | 175,048 | 04-30-2024 |
$34.02 | $34.23 | $34.02 | $34.34 | $34.01 | 283,132 | 04-29-2024 |
$34.06 | $34.34 | $34.06 | $34.5575 | $33.9964 | 175,824 | 04-26-2024 |
$34.12 | $33.85 | $34.12 | $34.29 | $33.48 | 307,543 | 04-25-2024 |
$33.66 | $32.25 | $33.66 | $33.67 | $32.04 | 276,850 | 04-24-2024 |
$32.03 | $31.6 | $32.03 | $32.23 | $31.6 | 144,847 | 04-23-2024 |
$31.83 | $31.22 | $31.83 | $31.97 | $31.085 | 145,420 | 04-22-2024 |
$31.06 | $30.38 | $31.06 | $31.24 | $30.38 | 264,312 | 04-19-2024 |
$30.46 | $30.22 | $30.46 | $30.875 | $30.22 | 274,838 | 04-18-2024 |
$30.16 | $30.8 | $30.16 | $30.94 | $30.07 | 196,202 | 04-17-2024 |
$30.61 | $30.62 | $30.61 | $30.81 | $30.37 | 138,344 | 04-16-2024 |
$30.9 | $30.71 | $30.9 | $31.08 | $30.63 | 191,370 | 04-15-2024 |
$30.67 | $30.75 | $30.67 | $30.77 | $30.5 | 104,119 | 04-12-2024 |
$30.97 | $30.92 | $30.97 | $31.135 | $30.75 | 161,118 | 04-11-2024 |
$30.94 | $31.29 | $30.94 | $31.29 | $30.6 | 201,647 | 04-10-2024 |
$32.13 | $31.92 | $32.13 | $32.15 | $31.82 | 192,880 | 04-09-2024 |
$31.73 | $31.5 | $31.73 | $31.9369 | $31.5 | 110,507 | 04-08-2024 |
$31.43 | $31.27 | $31.43 | $31.545 | $31.11 | 103,955 | 04-05-2024 |
$31.27 | $31.81 | $31.27 | $32.065 | $31.26 | 195,244 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Bank of N.T. Butterfield & Son Limited Voting Company Name:
NTB Stock Symbol:
NYSE Market:
2024-04-25 12:15:02 ET Piper Sandler analyst issues OVERWEIGHT recommendation for NTB on April 25, 2024 10:01AM ET. The previous analyst recommendation was Overweight. NTB was trading at $33.99 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Financial highlights for the first quarter of 2024: Net income of $53.4 million, or $1.13 per share, and core net income 1 of $55.0 million, or $1.17 per share Return on average common equity of 21.5% and core return on average tangible common equity 1 of 24.5% ...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...